论文部分内容阅读
重金属(主要指 pb~(2-))是许多医药原料控制项目的一个重要指标,pb~(2+)是一种对人体有害的物质,如果药品中含量过高,长期使用会对人体产生不良影响,因此必须加以控制。作者在从事进出口贸易中发现,目前药典规定的重金属 pb~(2+)检验方法不适用于进出口商检中的快速要求。现介绍一种 pb~(2+)的快速检验法——原子吸收分光光度法。
Heavy metals (mainly pb ~ (2-)) is an important indicator of many pharmaceutical raw materials control projects, pb ~ (2+) is a harmful substance to the human body, if the drug content is too high, long-term use will produce on the human body Adverse effects, therefore, must be controlled. The author found in the import and export trade, the current Pharmacopoeia heavy metal pb ~ (2+) test method does not apply to import and export commodity inspection in the rapid requirements. Now introduced a pb ~ (2 +) rapid test method - atomic absorption spectrophotometry.